All In Biotech

Drug Trial Radar · NCT01982240

12-Week Study of Plecanatide for CIC (The CIC3 Study)

A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)

Last checked: Nov 20, 2026Latest source record: Dec 26, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,394 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,394

Actual

Start

Nov 2013

Primary completion

Apr 2015

Study completion Jun 2015

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
Nov 13, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to confirm that the investigational medication, plecanatide, is safe and effective in treating chronic idiopathic constipation.

Conditions

  • Chronic Idiopathic Constipation

Interventions

  • PlecanatideDrug

    Plecanatide tablets QD for 12 weeks

  • PlaceboDrug

    Matching placebo tablets QD for 12 weeks

  • BisacodylDrug

    Rescue medication

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Durable Overall CSBM Responders , Mean Replacement ApproachTime frame: 12-week Treatment Period

Locations

189 sites in 2 countries. Site status is shown where the registry gives one.

  • Synergy Research Site

    Birmingham, Alabama

  • Synergy Research Site

    Dothan, Alabama

  • Synergy Research Site

    Gulf Shores, Alabama

  • Synergy Research Site

    Huntsville, Alabama

  • Synergy Research Site

    Mobile, Alabama

  • Synergy Research Site

    Mesa, Arizona

  • Synergy Research Site

    Phoenix, Arizona

  • Synergy Research Site

    Phoenix, Arizona

  • Synergy Research Site

    Tempe, Arizona

  • Synergy Research Site

    Tucson, Arizona

  • Synergy Research Site

    Hot Springs, Arkansas

  • Synergy Research Site

    Little Rock, Arkansas

  • Synergy Research Site

    North Little Rock, Arkansas

  • Synergy Research Site

    Anaheim, California

  • Synergy Research Site

    Anaheim, California

  • Synergy Research Site

    Carlsbad, California

  • Synergy Research Site

    Cerritos, California

  • Synergy Research Site

    Chula Vista, California

  • Synergy Research Site

    El Cajon, California

  • Synergy Research Site

    Encinitas, California

  • Synergy Research Site

    Encino, California

  • Synergy Research Site

    Fountain Valley, California

  • Synergy Research Site

    Fresno, California

  • Synergy Research Site

    Hawaiian Gardens, California

  • Synergy Research Site

    Lancaster, California

  • Synergy Research Site

    Long Beach, California

  • Synergy Research Site

    Los Angeles, California

  • Synergy Research Site

    Los Angeles, California

  • Synergy Research Site

    Los Angeles, California

  • Synergy Research Site

    Mission Hills, California

  • Synergy Research Site

    Murrieta, California

  • Synergy Research Site

    North Hollywood, California

  • Synergy Research Site

    Oceanside, California

  • Synergy Research Site

    Oxnard, California

  • Synergy Research Site

    Pasadena, California

  • Synergy Research Site

    Poway, California

  • Synergy Research Site

    Sacramento, California

  • Synergy Research Site

    San Diego, California

  • Synergy Research Site

    San Diego, California

  • Synergy Research Site

    San Diego, California

Showing 40 of 189 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.